Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
SOLARA
₹628
₹616.90
₹653.90
₹422.00
₹712.00
Markets Today
Historical Performance
As of 25-08-2026 00:49, Solara Active Pharma Sciences Ltd. share price today is ₹0, with a change of ₹-616.90 (-100.00%) from the previous close of ₹616.9. The stock opened at ₹618 and traded between ₹616.9 and ₹653.9, with a total traded volume of 613372 shares. The company has a market capitalization of ₹2964.7 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹712 and ₹422, respectively.
Solara Active Pharma Sciences Ltd. valuation metrics include a P/E ratio of -1830.1, EPS of ₹-1.68, and book value of ₹2.30. Profitability indicators show ROE of -0.59%. Solara Active Pharma Sciences Ltd. has reported revenue of ₹1431.43 Cr and net profit of ₹-1.62 Cr.
Solara Active Pharma Sciences Ltd. technical indicators include Day RSI at 68.62, Day MFI at 94.79, Day ADX at 27.83. Additional indicators include Commodity Channel Index (CCI) at 284.2 and Williams %R at -23.92. Momentum indicators show Day MACD at 10.95, Day MACD Signal Line at -3.25, DayATR at 27.24. Rate of Change indicators for Solara Active Pharma Sciences Ltd. include ROC125 at 27.54 and ROC21 at 17.79.
Exponential moving averages include EMA5 at ₹584.5, EMA10 at ₹558.7, EMA12 at ₹553.3, EMA20 at ₹544, EMA26 at ₹542.4, EMA50 at ₹541.3, EMA100 at ₹537.2, EMA200 at ₹540. Simple moving averages include SMA5 at ₹573, SMA10 at ₹542.4, SMA20 at ₹526.4, SMA30 at ₹536.6, SMA50 at ₹551.8, SMA100 at ₹533.3, SMA150 at ₹517, SMA200 at ₹528.8.
Support levels for Solara Active Pharma are placed at First Support ₹604.43, Second Support ₹591.97, Third Support ₹574.93. Resistance levels are seen at First Resistance ₹633.93, Second Resistance ₹650.97, Third Resistance ₹663.43. Solara Active Pharma Sciences Ltd. shareholding pattern shows promoter holding at 41.93%, FII holding at 11.52%, DII holding at 0%, public holding at 42.79%.
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 381.60 | 387.29 | 349 | 313.54 | 319.15 |
| Operating Expense | 319.59 | 329.74 | 311.65 | 278.79 | 262.12 |
| Operating Profit | 62.01 | 57.55 | 37.35 | 34.75 | 57.03 |
| Depreciation | 26.71 | 26.04 | 25.57 | 24.49 | 23.58 |
| Interest | 20.23 | 27.06 | 22.45 | 20.83 | 23.90 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 16.99 | 9.73 | -17.42 | -10.08 | 10.53 |
₹628.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 37.9 | 42 | 42 | 42 | 42 | 41.9 |
| FII | 14.6 | 14.2 | 13.6 | 12 | 11.6 | 11.5 |
| DII | 2.6 | 2.7 | 2.7 | 3.6 | 3.7 | 3.8 |
| Public | 44.8 | 41.1 | 41.7 | 42.4 | 42.7 | 42.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.97 L | 7.76 L | 25.43% |
| Week | 2.73 L | 17.72 L | 15.38% |
| 1 Month | 1.51 L | 6.2 L | 24.30% |
| 6 Month | 91.91 K | 3.08 L | 29.88% |
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Growth in Net Profit with increasing Profit Margin (QoQ)
Increasing profits every quarter for the past 2 quarters
Book Value per share Improving for last 2 years
Stock with Low PE (PE < = 10)
RSI indicating price strength
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Aug, 2021 | 3 | FINAL | Equity Share | |
| 19 Nov, 2020 | 4 | INTERIM | 20 Nov, 2020 | Equity Share |
| 28 Jul, 2020 | 2 | FINAL | Equity Share | |
| 06 Aug, 2019 | 5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹526.25 | ₹6.55 | ₹205.20 | ₹15.46 | ₹61.70 | ₹2,638 |
| % Change | -2.70% | 4.97% | 4.81% | 8.26% | 2.83% | 0.05% |
| Revenue TTM (₹ Cr) | ₹526.28 | ₹69.99 | ₹291.17 | ₹226.23 | ₹83.19 | ₹734.29 |
| Net Profit TTM (₹ Cr) | ₹20.77 | ₹-176.47 | ₹14.68 | ₹31.63 | ₹13.21 | ₹119.64 |
| PE TTM | 115.10 | -0.30 | 51.80 | 2.40 | 13.40 | 36.40 |
| 1 Year Return | 37.97 | 524 | 55.39 | 56.92 | -58.43 | 11.81 |
| ROCE | 3.56 | -56.37 | - | 17.36 | 5.25 | 23.90 |
Bafna Pharmaceuticals Ltd.
₹ 254.55
+4.99%
Alpa Laboratories Ltd.
₹ 61.20
-2.47%
SMS Pharmaceuticals Ltd.
₹ 354.00
-0.73%
Nectar Lifesciences Ltd.
₹ 10.80
+3.15%
Mangalam Drugs and Organics Ltd.
₹ 30.44
+9.97%
Indoco Remedies Ltd.
₹ 220.00
-2.78%
Ind-Swift Laboratories Ltd.
₹ 325.35
-1.29%
Lincoln Pharmaceuticals Ltd.
₹ 612.00
-0.33%
Panacea Biotec Ltd.
₹ 406.50
-1.12%
Medicamen Biotech Ltd.
₹ 234.00
-4.31%
Themis Medicare Ltd.
₹ 120.50
+13.53%
Venus Remedies Ltd.
₹ 1693.10
-2.59%
Bal Pharma Ltd.
₹ 85.00
-1.08%
Hikal Ltd.
₹ 212.00
-1.67%
NGL Fine - Chem Ltd.
₹ 2878.60
-2.34%
Hester Biosciences Ltd.
₹ 2360.00
-0.33%
Natural Capsules Ltd.
₹ 165.10
+8.70%
Krebs Biochemicals & Industries Ltd.
₹ 54.25
+1.19%
Kilitch Drugs(I) Ltd.
₹ 168.30
+3.68%
Syncom Formulation (India) Ltd.
₹ 17.28
+7.06%
Aarey Drugs & Pharmaceuticals Ltd.
₹ 77.71
-4.30%
Biofil Chemicals & Pharmaceuticals Ltd.
₹ 32.50
+7.40%
Aarti Drugs Ltd.
₹ 423.00
+1.34%
Wanbury Ltd.
₹ 262.50
-0.89%
Kopran Ltd.
₹ 195.49
-0.31%
By signing up I certify terms, conditions & privacy policy